Patents by Inventor Jens-Uwe Peters

Jens-Uwe Peters has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Malonamide derivatives
    Publication number: 20050054633
    Abstract: The invention relates to malonamide derivatives of formula wherein each of the variables are as defined herein and to pharmaceutically acceptable acid addition salts, optically pure enantiomers, racemates and diastereomeric mixtures thereof. These compounds are ?-secretase inhibitors and may be used for the treatment of Alzheimer's disease.
    Type: Application
    Filed: September 2, 2004
    Publication date: March 10, 2005
    Inventors: Alexander Flohr, Guido Galley, Roland Jakob-Roetne, Eric Kitas, Jens-Uwe Peters, Wolfgang Wostl
  • Substituted imidazo [1,2-a] pyridine derivatives
    Patent number: 6861437
    Abstract: The present invention is a series of novel compounds of formula I and a method of treatment or prevention of a mGluR5 receptor mediated disease by administering an therapeutically effective amount of a compound formula wherein R1 and R2 are selected from hydrogen, (C1-6)-alkyl, halogen, hydroxy, (C1-6)-alkoxy and A is defined the description, or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: April 4, 2003
    Date of Patent: March 1, 2005
    Assignee: Hoffman-La Roche Inc.
    Inventors: Vincent Mutel, Jens-Uwe Peters, Juergen Wichmann
  • Benzoxazepinone derivatives
    Publication number: 20040235819
    Abstract: The invention relates to benzoxazepinone derivatives of formula 1
    Type: Application
    Filed: May 3, 2004
    Publication date: November 25, 2004
    Inventors: Guido Galley, Robert Alan Goodnow, Jens-Uwe Peters
  • Malonamide derivatives
    Publication number: 20040220222
    Abstract: The invention relates to malonamide derivatives of formula 1
    Type: Application
    Filed: January 29, 2004
    Publication date: November 4, 2004
    Inventors: Guido Galley, Annick Goergler, Helmut Jacobsen, Eric Argirios Kitas, Jens-Uwe Peters
  • Pyridine and quinoline derivatives
    Patent number: 6800650
    Abstract: The present invention provides compounds of formula (I) wherein R1, R2, R3 and R4 are as defined in the specification, and pharmaceutically acceptable salts thereof. The compounds are useful for the treatment and/or prophylaxis of diseases which are associated with DPP IV, such as diabetes, particularly non-insulin dependent diabetes mellitus, and impaired glucose tolerance.
    Type: Grant
    Filed: February 11, 2003
    Date of Patent: October 5, 2004
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Markus Boehringer, Bernd Michael Loeffler, Jens-Uwe Peters, Claus Riemer, Peter Weiss
  • Substituted imidazo[1,2-a]pyridine derivatives
    Publication number: 20040180921
    Abstract: The present invention is a series of novel compounds of formula I and a method of treatment or prevention of a mGluR5 receptor mediated disease by administering an therapeutically effective amount of a compound formula 1
    Type: Application
    Filed: March 25, 2004
    Publication date: September 16, 2004
    Inventors: Vincent Mutel, Jens-Uwe Peters, Juergen Wichmann
  • Phenylethynyl and styryl derivatives of imidazole and fused ring heterocycles
    Patent number: 6706707
    Abstract: This invention relates to a compound and the use of the compound of the formula wherein R1, R2, R3, R4 and R5 are as defined in the description, A signifies —CH═CH— or —C≡C—; and B signifies wherein R6 to R26, X and Y are as defined in the specification or a pharmaceutically acceptable salt thereof, for use in pharmaceutical compositions for the treatment or prevention of mGluR5 receptor mediated disorders.
    Type: Grant
    Filed: November 28, 2001
    Date of Patent: March 16, 2004
    Assignee: Hoffman-La Roche Inc.
    Inventors: Vincent Mutel, Jens-Uwe Peters, Juergen Wichmann
  • Phenylethynyl and styryl derivatives of imidazole and fused ring heterocycles
    Publication number: 20030225070
    Abstract: This invention relates to the treatment of mGluR5 receptor mediated disorders, which comprises administering to a person in need of treatment a compound having the formula 1
    Type: Application
    Filed: April 4, 2003
    Publication date: December 4, 2003
    Inventors: Vincent Mutel, Jens-Uwe Peters, Juergen Wichmann
  • Pyridine and pyrimidine derivatives
    Publication number: 20030216382
    Abstract: The present invention provides compounds of formula (I) 1
    Type: Application
    Filed: February 10, 2003
    Publication date: November 20, 2003
    Inventors: Markus Boehringer, Bernd Michael Loeffler, Jens-Uwe Peters, Matthias Steger, Peter Weiss
  • Substituted imidazo [1,2-a] pyridine derivatives
    Publication number: 20030212096
    Abstract: The present invention is a series of novel compounds of formula I and a method of treatment or prevention of a mGluR5 receptor mediated disease by administering an therapeutically effective amount of a compound formula 1
    Type: Application
    Filed: April 4, 2003
    Publication date: November 13, 2003
    Inventors: Vincent Mutel, Jens-Uwe Peters, Juergen Wichmann
  • Phenylethynyl and styryl derivatives of imidazole and fused ring heterocycles
    Publication number: 20030208082
    Abstract: This invention relates to a compound and the use of the compound of the formula 1
    Type: Application
    Filed: March 25, 2003
    Publication date: November 6, 2003
    Inventors: Vincent Mutel, Jens-Uwe Peters, Juergen Wichmann
  • Pyridine and quinoline derivatives
    Publication number: 20030195188
    Abstract: The present invention provides compounds of formula (I) 1
    Type: Application
    Filed: February 11, 2003
    Publication date: October 16, 2003
    Inventors: Markus Boehringer, Bernd Michael Loeffler, Jens-Uwe Peters, Claus Riemer, Peter Weiss
  • Substituted imidazo[1,2-A] pyridine derivatives
    Patent number: 6596731
    Abstract: The present invention is a series of novel compounds of formula I and a method of treatment or prevention of a mGluR5 receptor mediated disease by administering an therapeutically effective amount of a compound formula wherein R1 and R2 are selected from hydrogen, (C1-6)-alkyl, halogen, hydroxy, (C1-6)-alkoxy and A is defined the description, or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: March 8, 2002
    Date of Patent: July 22, 2003
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Vincent Mutel, Jens-Uwe Peters, Juergen Wichmann
  • 4-aminopyrimidine derivatives
    Publication number: 20030022907
    Abstract: This invention is 4-aminopyrimidine derivatives of the formula 1
    Type: Application
    Filed: April 29, 2002
    Publication date: January 30, 2003
    Inventors: Vincent Mutel, Jens-Uwe Peters, Juergen Wichmann
  • Substituted imidazo[1,2-A] pyridine derivatives
    Publication number: 20020188128
    Abstract: The present invention is a series of novel compounds of formula I and a method of treatment or prevention of a mGluR5 receptor mediated disease by administering an therapeutically effective amount of a compound formula 1
    Type: Application
    Filed: March 8, 2002
    Publication date: December 12, 2002
    Inventors: Vincent Mutel, Jens-Uwe Peters, Juergen Wichmann
  • Phenylethynyl and styryl derivatives of imidazole and fused ring heterocycles
    Publication number: 20020128263
    Abstract: This invention relates to a compound and the use of the compound of the formula 1
    Type: Application
    Filed: November 28, 2001
    Publication date: September 12, 2002
    Inventors: Vincent Mutel, Jens-Uwe Peters, Juergen Wichmann